The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Colchicine Update: 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
ARTHRITIS AND ALLIED CONDITIONS
BERNARD I. COMROE, T. L., & HOLLANDER, J. L. (1949) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194911000-00026 · Cited by 1,581
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
Pétrilli, V, Papin, S., Dostert, C., Mayor, A., Martinon, F., & Tschopp, J. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402195 · Cited by 1,445
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Imazio, M., Bobbio, M., Cecchi, E., Demarie, D., Demichelis, B., Pomari, F., Moratti, M., Gaschino, G., Giammaria, M., Ghisio, A., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.542738 · Cited by 614
Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhattacharyya, B., Panda, D., Gupta, S., & Banerjee, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20097 · Cited by 499
Masuda, K., Urayama, A., Kogure, M., Nakajima, A., Nakae, K., & Inaba, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92381-7 · Cited by 490
Terkeltaub, R. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030733 · Cited by 456
Self-citationImazio, M., Bobbio, M., Cecchi, E., Demarie, D., Pomari, F., Moratti, M., Ghisio, A., Belli, R., & Trinchero, R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1987 · Cited by 424
Cronstein, B. N., Molad, Y., Reibman, J., Balakhane, E., Levin, R. I., & Weissmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118147 · Cited by 388
A double-blind trial of colchicine in Beh�et's syndrome
Yurdakul, S., Mat, C., T�z�n, Y., �zyazgan, Y., Hamuryudan, V., Uysal, �., ?enocak, M., & Yazici, H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h · Cited by 383
Ben-Chetrit, E., & Levy, M. (1998) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(98)80028-0 · Cited by 354
Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
Borstad, G. C., Bryant, L. R., Abel, M. P., Scroggie, D. A., Harris, M. D., & Alloway, J. A. (2004) · PubMed · Cited by 328
Janssens, H. J., Janssen, M., van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60799-0 · Cited by 317
USES AND ABUSES OF CHLORMETHIAZOLE
Exton-Smith, A. N., Mclean, A. E. M., Majumdar, S., Glatt, M. M., & Scott, C. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92998-2 · Cited by 309
Pyrin Activates the ASC Pyroptosome in Response to Engagement by Autoinflammatory PSTPIP1 Mutants
Yu, J.-W., Fernandes-Alnemri, T., Datta, P., Wu, J., Juliana, C., Solorzano, L., McCormick, M., Zhang, Z., & Alnemri, E. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.029 · Cited by 287
Niel, E., & Scherrmann, J.-M. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.03.006 · Cited by 286
DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT
AHERN, M. J., REID, C., GORDON, T. P., McCREDlE, M., BROOKS, P. M., & JONES, M. (1987) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1987.tb01232.x · Cited by 284
Marchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
Shukla, S., Wu, C.-P., & Ambudkar, S. V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.205 · Cited by 253
The inflammatory process of gout and its treatment.
Cronstein, B. N., & Terkeltaub, R. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1908 · Cited by 216
Self-citationNidorf, M., & Thompson, P. L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.039 · Cited by 201
Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation
Nuki, G. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0036-3 · Cited by 199
Mansfield, E., Chae, J. J., Komarow, H. D., Brotz, T. M., Frucht, D. M., Aksentijevich, I., & Kastner, D. L. (2001) · Blood · doi:10.1182/blood.v98.3.851 · Cited by 197
MDR- and CYP3A4-Mediated Drug–Drug Interactions
Pal, D., & Mitra, A. K. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9034-2 · Cited by 181
Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein
Loo, T. W., Bartlett, M. C., & Clarke, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300073200 · Cited by 174
van Echteld, I., Wechalekar, M. D., Schlesinger, N., Buchbinder, R., & Aletaha, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006190.pub2 · Cited by 162
Heterotropic Cooperativity of Cytochrome P450 3A4 and Potential Drug-Drug Interactions
Tang, W., & Stearns, R. (2001) · Current Drug Metabolism · doi:10.2174/1389200013338658 · Cited by 162
CYP3A4 Substrate Selection and Substitution in the Prediction of Potential Drug-Drug Interactions
Galetin, A., Ito, K., Hallifax, D., & Houston, J. B. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082826 · Cited by 158
Artom, G., Koren‐Morag, N., Spodick, D. H., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi197 · Cited by 154
Modulation of Microtubule Dynamics by Drugs. A Paradigm for the Actions of Cellular Regulators.
Wilson, L., Panda, D., & Jordan, M. A. (1999) · Cell Structure and Function · doi:10.1247/csf.24.329 · Cited by 153
Ben‐Chetrit, E., Bergmann, S., & Sood, R. (2005) · Rheumatology · doi:10.1093/rheumatology/kei140 · Cited by 142
P‐glycoprotein: So Many Ways to Turn It On
Callaghan, R., Crowley, E. H., Biochem, M., Potter, S., & Kerr, I. D. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007311568 · Cited by 140
Hung, I. F., Wu, A. K. L., Cheng, V. C., Tang, B. S. F., To, K. K., Yeung, C., Woo, P. C. Y., Lau, S. K. P., Cheung, B., & Yuen, K. (2005) · Clinical Infectious Diseases · doi:10.1086/431592 · Cited by 130
Genuine Functions of P-Glycoprotein (ABCB1)
Mizutani, T., Masuda, M., Nakai, E., Furumiya, K., Togawa, H., Nakamura, Y., Kawai, Y., Nakahira, K., Shinkai, S., & Takahashi, K. (2008) · Current Drug Metabolism · doi:10.2174/138920008783571756 · Cited by 129
Rochdi, M., Sabouraud, A. E., Girre, C., Venet, R., & Scherrmann, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194404 · Cited by 126
Colchicine Myotoxicity: Case Reports and Literature Review
Wilbur, K., & Makowsky, M. J. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.17.1784.52334 · Cited by 125
Ferron, G. M., Rochdi, M., Jusko, W. J., & Scherrmann, J. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04753.x · Cited by 116
C-reactive protein and atherogenesis: From fatty streak to clinical event
Bisoendial, R. J., Kastelein, J. J. P., & Stroes, E. S. G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.04.053 · Cited by 95
Pathogenesis and treatment of crystal-induced inflammation
Terkeltaub, R. A. (1993) · Cited by 94
Self-citationColchicine Glycorandomization Influences Cytotoxicity and Mechanism of Action
Ahmed, A., Peters, N. R., Fitzgerald, M., James A. Watson, Hoffmann, F. M., & Thorson, J. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064686s · Cited by 93
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study.
Richette, P., Brière, C., Hoenen-Clavert, V., Lœuille, D., & Bardin, T. (2007) · PubMed · Cited by 91
Genomics and the mechanism of P-glycoprotein (ABCB1)
Sauna, Z. E., Kim, I., & Ambudkar, S. V. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9115-9 · Cited by 87
Multiple Sequential Steps Involved in the Binding of Inhibitors to Cytochrome P450 3A4
Isin, E. M., & Guengerich, F. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610346200 · Cited by 81
Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine
Alaylı, G., Cengiz, K., Cantürk, F., Durmuş, D., Akyol, Y., & Menekse, E. B. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e593 · Cited by 79
Acute Colchicine Intoxication During Clarithromycin Administration
Rollot, F., Pajot, O., Chauvelot‐Moachon, L., et al. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e197 · Cited by 77
Colchicine-Induced Acute Myopathy in a Patient With Concomitant Use of Simvastatin
Hsu, W.-C., Chen, W., Chang, M., & Chiu, H. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200209000-00008 · Cited by 74
Cytoskeletal myotoxicity from simvastatin and colchicine
Baker, S. K., Goodwin, S., Sur, M., & Tarnopolsky, M. A. (2004) · Muscle & Nerve · doi:10.1002/mus.20135 · Cited by 70
Discovery of novel immunostimulants by dendritic-cell–based functional screening
Mizumoto, N., Gao, J., Matsushima, H., Ogawa, Y., Tanaka, H., & Takashima, A. (2005) · Blood · doi:10.1182/blood-2005-03-1161 · Cited by 69
Rhabdomyolysis in a Patient Treated with Colchicine and Atorvastatin
Tufan, A., Dede, D. Ş., Cavus, S., et al. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h064 · Cited by 68
Schlesinger, N., Schumacher, R. H., Catton, M., & Maxwell, L. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006190 · Cited by 61
Calcagno, A. M., Kim, I., Wu, C., Shukla, S., & Ambudkar, S. V. (2007) · Current Drug Delivery · doi:10.2174/156720107782151241 · Cited by 58
Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance
Li, X., Yuan, H., Wu, J., Li, J., Qu, X., Xu, W., & Tang, W. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503258 · Cited by 57
Misra, S., Varticovski, L., & Arias, I. M. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00048.2003 · Cited by 51
Possible colchicine rhabdomyolysis in a fluvastatin-treated patient
Atasoyu, E. M., Evrenkaya, T. R., & Solmazgül, E. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e653 · Cited by 45
Peachman, K. K., Rao, M., Palmer, D. R., Zidanic, M., Sun, W., Alving, C. R., & Rothwell, S. W. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.013 · Cited by 34
McKeown, N. J., Horowitz, B. Z., Garlich, F. M., Young, C., & Robertson, W. O. (2007) · MMWR Morbidity and Mortality Weekly Report · Cited by 34
Therapeutic opportunities to control tumor cell cycles
Malumbres, M. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0193-7 · Cited by 31
Evil humors take their toll as innate immunity makes gouty joints TREM‐ble
Liu‐Bryan, R., & Terkeltaub, R. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21634 · Cited by 29
Self-citationColchicine use in cyclosporine treated transplant recipients: how little is too much?
Simkin, P. A., & Gardner, G. C. (2000) · PubMed · Cited by 28
Imazio, M., Cecchi, E., Ierna, S., & Trinchero, R. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000281702.46359.07 · Cited by 28
Colchicine Inhibits Intimal Hyperplasia and Leukocyte VEGF Expression in Dogs
Atta, H. M., Elrehany, M. A., Abdelraheim, S. R., Fouad, R., & Galal, A. M. F. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.04.029 · Cited by 21
Colchicine Promotes Antigen Cross-Presentation by Murine Dendritic Cells
Mizumoto, N., Tanaka, H., Matsushima, H., Vishwanath, M., & Takashima, A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700699 · Cited by 18
Lee, S., Namkoong, S., Ha, K., Nam, W. D., Kwon, Y. U., Lee, H., Yoon, E.-Y., Chang, D.-J., Kim, S.-O., & Kim, Y. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.26 · Cited by 9
Cited by
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Colchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Colchicine poisoning: the dark side of an ancient drug
Finkelstein, Y., Aks, S. E., Hutson, J. R., Juurlink, D. N., Nguyen, P., Dubnov-Raz, G., Pollak, U., Koren, G., & Bentur, Y. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.495348 · Cited by 589
Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27327 · Cited by 536
Self-citationUpdate on gout: new therapeutic strategies and options
Terkeltaub, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.236 · Cited by 387
Self-citation
Metadata
- Authors
- Terkeltaub, R. A.
- Venue
- Seminars in Arthritis and Rheumatism
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 38
- Issue
- 6
- Pages
- 411-419
- ISSN
- 0049-0172 (ISSN-L)
- OpenAlex
- W1967152930
- Cited by
- 299
- References
- 68
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.